A series of new reports has raised concerns over potential links between popular weight loss medications and vision loss. Several studies indicate that drugs such as Ozempic and Mounjaro, which contain semaglutide and tirzepatide, may contribute to conditions leading to severe and possibly permanent blindness.
Researchers recently highlighted nine cases in the United States where individuals experienced vision loss after using these drugs. In one documented instance, a woman experienced blindness in her left eye the morning after receiving her first injection of semaglutide. Despite stopping the medication, she had to resume it due to her diabetes, only to lose vision in her right eye shortly after.
Another case involved a woman taking semaglutide for a year. She developed vision issues because of retinal blood vessel damage. Additionally, a man suffered eye bleeding linked to tirzepatide, though he was advised to continue the medication due to insufficient evidence of the drug causing his condition.
Experts suggest that rapid reductions in blood sugar levels associated with these weight loss drugs might harm eye blood vessels, resulting in vision loss.
Despite these findings, causation has not been definitively proved. The American Academy of Ophthalmology has advised patients experiencing vision problems while on semaglutide to consult their physicians, but has not advised against the drug’s use overall. […]
— Read More: thenationalpulse.com
